We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biotronics3D and Institute of Cancer Research Collaborate to Develop MRI Oncology Software

By HospiMedica International staff writers
Posted on 12 Aug 2009
Biotronics3D (London, UK) has partnered with the Institute of Cancer Research (ICR) to develop and launch software to improve the effectiveness of magnetic resonance imaging (MRI) scan analysis. More...
Called 3D Net Perfusion, the system extracts data from images of tumors and transforms it into usable information.

A powerful analytic tool, 3D Net Perfusion enables clinicians to gain clearer comprehension of MRI scans, improving the accuracy of diagnosis and assessment of treatment efficacy. It is also an innovative way of visualizing and measuring the blood supply to cancers--a crucial factor in tumor growth.

The software is the result of pioneering trials at the ICR led by Prof. Martin Leach, David Collins, and James d'Arcy, and is currently used in 10 research centers. Scientists from the ICR continue to work with Biotronics3D software developers to further enhance the product. Paul Carnochan, senior business development manager at the ICR, believes the partnership could have broader implications and stated, "London has an abundance of research capabilities and commercial expertise in the field of medical imaging, and we believe that collaborations like this one can be the key to raising London's profile as a major biotech hub.”

Harry Hatzakis, CEO of Biotronics 3D, commented, "Innovation carries risks and in fast moving markets such as global diagnostics it is important to leverage skills that exist outside the company through partnerships such as ours with the ICR.”

The Institute of Cancer Research (ICR) is one of Europe's leading cancer research centers with expert scientists working on cutting-edge research. In 2009, the ICR marks its 100 years of groundbreaking research into cancer prevention, diagnosis, and treatment.

Biotronics3D develops and markets software applications for the diagnostic imaging industry. The company provides software technologies to improve healthcare by better extracting diagnostic data and transforming it into usable information available at the point-of-care. Biotronics3D, Ltd. is an EN ISO 13485:2003-certified company and its flagship product, 3Dnet Suite received FDA 510K market clearance, and it is CE marked.

Related Links:

Biotronics3D
The Institute of Cancer Research



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Resorbable Bovine Collagen Membrane
GenDerm
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.